MAAT INDEX

CLAIM #12276 · Bristol-Myers Squibb Company (BMY) · 2026Q1 earnings call · Apr 30, 2026 · due Dec 31, 2026

For the moment, we are on track for a year-end readout.

Cristian Massacesi · Chief Medical Officer

PENDING
graded after results covering Dec 31, 2026 are reported

How to check this claim

Look at: Disclosure of topline/readout data for the trial referenced

It came true if: Company or partner announces readout (topline results disclosed) on or before 2026-12-31

Where: Company press release, earnings call, or clinicaltrials.gov posting of results

Verify independently

SEC filings for BMY · Claim quote is verbatim from the 2026Q1 earnings call.